News & Updates

STEMI hospitalizations down during pandemic
STEMI hospitalizations down during pandemic
26 Dec 2021
Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
25 Dec 2021

For older acute coronary syndrome (ACS) patients with implanted bioabsorbable polymer sirolimus-eluting stents, a strategy involving ticagrelor monotherapy after 3‐month dual antiplatelet therapy (DAPT) is better than ticagrelor‐based 12‐month DAPT, according to a post hoc analysis of the TICO* trial. Furthermore, the beneficial effect of ticagrelor monotherapy increases with age and is strongest among patients aged ≥64 years.

Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
25 Dec 2021
Statin adherence a must to reduce stroke risk among hyperlipidemia patients
Statin adherence a must to reduce stroke risk among hyperlipidemia patients
24 Dec 2021

Patients with hyperlipidemia who take their statin medication as prescribed appear to do well, with treatment adherence conferring significant protection against the risk of ischaemic and haemorrhagic strokes, as reported in a study.

Statin adherence a must to reduce stroke risk among hyperlipidemia patients
24 Dec 2021
COVID-19 causes lighter heart damage during second vs first wave of infections
COVID-19 causes lighter heart damage during second vs first wave of infections
20 Dec 2021

In fatal cases of the coronavirus disease 2019 (COVID-19), cardiac inflammation, cardiomyocyte injury, and microvascular thrombogenicity are substantially lower in the second vs first wave of infections, a new study has found.

COVID-19 causes lighter heart damage during second vs first wave of infections
20 Dec 2021